Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of a Single Transrectal Ultrasound(TRUS)-Guided Intraprostatic Injection of NX-1207 in Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Phase III European Study
Conditions
Interventions
NX-1207
Tamsulosin
Locations
5
Germany
Klinikum der Ludwig-Maximilians-universität München
Munich, Germany
Vita e Salute University, Department of Urology, Istituto Scientifico Ospedale San Raffaele
Milan, Italy
Niepubliczny Zaklad Opieki Zdrowotnej Specjalista
Kutno, Poland
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital
Sheffield, United Kingdom
Start Date
September 1, 2013
Primary Completion Date
January 29, 2015
Completion Date
January 29, 2015
Last Updated
May 26, 2022
NCT07451548
NCT03802851
NCT04627701
NCT06225479
NCT05739071
NCT05869734
Lead Sponsor
RECORDATI GROUP
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions